International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs

被引：1
|
作者：
Caruso, C. [1 ]
Canonica, G. W. [2 ]
Patel, M. [3 ]
Smith, A. [3 ]
Liu, M. C. [4 ]
Alfonso-Cristancho, R. [5 ]
Price, R. G. [6 ]
Jakes, R. W. [7 ]
Demetriou, L. [8 ]
Valero, A. [9 ]
Pilette, C. [10 ]
Howarth, P. [11 ]
机构：
[1] Fdn Policlin Gemelli, IRCCS, UOSD DH Gastroenterol, Rome, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Univ Hosp Wishaw, Dept Resp Med, Wishaw, Scotland
[4] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, Biostat, Stevenage, Herts, England
[7] GSK, Epidemiol, GSK House, Brentford, England
[8] GSK, Value Evidence & Outcomes, Stevenage, Herts, England
[9] Univ Barcelona, IDIBAPS, CIBER Enfermedades Respiratorias CIBERES, Hosp Clin Barcelona,Secc Alergol,Serv Neumol & Al, Barcelona, Spain
[10] CIBER Enfermedades Resp CIBERES, IDIBAPS, Barcelona, Spain
[11] Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4589
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4589
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid GERD or Anxiety/Depression: Post Hoc Analysis of REALITI-A
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Maxwell, Aoife
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Lee, Jason
    Cheema, Amarjit
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [22] Mepolizumab Provides Real-World Clinical Benefits in Severe Eosinophilic Asthma Irrespective of Baseline Lung Function: Results From the REALITI-A Study at 2 Years
    Bagnasco, D.
    Pilette, C.
    Lougheed, M.
    Caruso, C.
    Echave-Sustaeta, J.
    Dennison, P.
    Verghis, R.
    Jakes, R.
    Rais, M.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] Effectiveness and safety of mepolizumab in real-world clinical practice: The REALITI-A study
    Harrison, T.
    Canonica, G.
    Gemzoe, K.
    Maxwell, A.
    Yang, S.
    Joksaite, S.
    O'Reilly, R.
    Van Dyke, M.
    Albers, F. C.
    Kwon, N.
    [J]. PNEUMOLOGIE, 2020, 74 : S25 - S25
  • [24] The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: Post hoc analysis of REALITI-A at 2 years
    Canonica, G. W.
    Demetriou, L.
    Schleich, F.
    Pelaia, G.
    Bernstein, D.
    Lee, F. E. H.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 185 - 186
  • [25] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [26] Mepolizumab improves lung function under real-world settings in REALITI-A study
    Schleich, Florence
    Chaudhuri, Rekha
    Canonica, Giorgio Walter
    Munoz Gall, Xavier
    Funke, Faustina
    Pek, Bonavuth
    Pollard, Stephen
    Maxwell, Aoife
    Joksaite, Sandra
    Price, Robert G.
    O'Reilly, Ronan
    Van Dyke, Melissa K.
    Yang, Shibing
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 50 - 51
  • [28] Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A
    Lee, Frances
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15
  • [29] UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years
    Weir, J.
    Egan, B.
    Heaney, L.
    Menzies, D.
    Pfeffer, P.
    Howarth, P.
    Chaudhuri, R.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A184 - A184
  • [30] Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study
    Harrison, Tim
    Canonica, G. Walter
    Gemzoe, Kim
    Maxwell, Aoife
    Yang, Shibing
    Joksaite, Sandra
    O'Reilly, Ronan
    Van Dyke, Melissa
    Albers, Frank C.
    Kwon, Namhee
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345